Allsino Pharmaceutical Co., Ltd.

Allsino Pharmaceutical Co., Ltd. was founded in 2004 by a group of aspiring chemists with extensive experiences in both US and China pharmaceutical industry. In December 2016，Allsino merged with Sinopep but continues to operate independently as a 100% subsidiary company of Sinopep-Allsino Biopharmaceuticals. As premier Contract Development and Manufacturing Organization (CDMO), Allsino offers worldwide clients an intergraded and exclusive customer synthesis service of small molecules & peptide fragments. Over the years, Allsino Pharmaceutical has demonstrated deep understanding of synthetic chemistry and powerful production capability to meet customers’ complicate needs.